Bioethics

EQS-News: Abivax Provides Operational and Key Program Update

Retrieved on: 
Monday, July 15, 2024

With Ms. Grégoire joining the Board of Directors, Carol Brosgart, MD will be resigning from the Abivax Board.

Key Points: 
  • With Ms. Grégoire joining the Board of Directors, Carol Brosgart, MD will be resigning from the Abivax Board.
  • Mr. de Garidel said “On behalf of the Abivax Board of Directors, I would like to warmly welcome Sylvie           to the team.
  • These adjustments to the obefazimod CD clinical program are not expected to have an impact on the overall program budget and projected supplemental New Drug Application (sNDA) submission timeline.
  • Selection of the first follow-on drug candidate is expected before the end of 2024 to further strengthen the Abivax pipeline.

Abivax Provides Operational and Key Program Update

Retrieved on: 
Monday, July 15, 2024

With Ms. Grégoire joining the Board of Directors, Carol Brosgart, MD will be resigning from the Abivax Board.

Key Points: 
  • With Ms. Grégoire joining the Board of Directors, Carol Brosgart, MD will be resigning from the Abivax Board.
  • Mr. de Garidel said “On behalf of the Abivax Board of Directors, I would like to warmly welcome Sylvie           to the team.
  • These adjustments to the obefazimod CD clinical program are not expected to have an impact on the overall program budget and projected supplemental New Drug Application (sNDA) submission timeline.
  • We deeply appreciate all his contributions to Abivax and to the ABTECT program which include recruiting and building the medical team functions of Pharmacovigilance, Clinical Development, Clinical Pharmacology, Biometrics and Medical Affairs.

U.S. Supreme Court Backs Local Communities in Nation's Homeless Response

Retrieved on: 
Friday, June 28, 2024

SEATTLE, June 28, 2024 /PRNewswire/ -- Discovery Institute praised the Supreme Court ruling in Grants Pass v. Johnson that city ordinances against public camping do not constitute "cruel and unusual punishment" under the Eighth Amendment.

Key Points: 
  • SEATTLE, June 28, 2024 /PRNewswire/ -- Discovery Institute praised the Supreme Court ruling in Grants Pass v. Johnson that city ordinances against public camping do not constitute "cruel and unusual punishment" under the Eighth Amendment.
  • The Supreme Court's ruling on Grants Pass v Johnson is a great first step in giving authority back to local governments.
  • "The Supreme Court's reversal of the Ninth Circuit's opinion in the City of Grants Pass v. Johnson is a great first step in giving authority back to local governments to address the homelessness crisis," said Robert Marbut, former Executive Director of the U.S. Interagency Council on Homelessness.
  • "If this opinion is combined with proposed legislation such as Rep. Andy Barr's (KY-6th) Housing PLUS Act, we can start to significantly reduce homelessness."

Cache Raises Seed Financing to Advance its Biomolecule Storage Technologies

Retrieved on: 
Tuesday, May 7, 2024

Cache DNA, Inc. , a life sciences company revolutionizing biological sample and data storage infrastructure, today announced the closing of its seed round.

Key Points: 
  • Cache DNA, Inc. , a life sciences company revolutionizing biological sample and data storage infrastructure, today announced the closing of its seed round.
  • The funds will help power R&D and support commercial development efforts and key partnerships to bring their solutions to market.
  • “Over the past three decades, sequencing technologies have evolved drastically.
  • It feels like every month, a new sequencing method is developed,” says Michael Becich, Cache CEO.

Pyx Health Expands Female-Forward Senior Leadership Team to Fuel Major Growth Strategy

Retrieved on: 
Tuesday, April 16, 2024

TUCSON, Ariz., April 16, 2024 /PRNewswire/ -- Pyx Health, the leading social health platform solving loneliness, today announced that its Board of Directors has appointed Christina Rice, MBA, to president, and chief strategy officer, effective immediately. Co-founder Cindy Jordan will continue to serve as chief executive officer responsible for driving the company's direction, supervising other executives, and overseeing growth plans.

Key Points: 
  • Since 2018, she has served alongside Cindy Jordan as Pyx Health's chief operating officer, responsible for day-to-day operations while spearheading new strategies and growth opportunities.
  • As president, she oversees more than 200 employees nationwide and drives Pyx Health's service to 70+ healthcare clients and over 100,000 members.
  • "Pyx Health plays a critical role in the lives of those struggling with chronic loneliness across the country," said Rice.
  • Pyx Health's leadership team is comprised of 83% women and outpaces the national benchmarks for technology companies by employing an 81% female workforce.

Supreme Court Hears Oral Argument in Pivotal NCLA Case Against Gov’t Social Media Censorship

Retrieved on: 
Monday, March 18, 2024

The vast, coordinated silencing of First Amendment-protected speech has targeted influential, highly qualified voices including doctors and scientists like Drs.

Key Points: 
  • The vast, coordinated silencing of First Amendment-protected speech has targeted influential, highly qualified voices including doctors and scientists like Drs.
  • We went to social media to voice our opinions and were silenced by government employees who bullied social media snowflakes into silencing our voices.
  • In the Murthy v. Missouri case, the Supreme Court has the opportunity to restore the First Amendment in this country.
  • That is what the government did here, and if that is allowed then the First Amendment is a dead letter.”

Global Clinical Trials Connect Conference 2024: London, United Kingdom - May 28-29, 2024 - Registration Now Open - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 26, 2024

The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.
  • The Global Clinical Trials Connect 2024 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research.
  • This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
  • It gives us a great pleasure in welcoming you to the Global Clinical Trials Connect 2024.

CUTTING-EDGE RESEARCH SHAPING CHILDREN'S HEALTH SHOWCASED AT THE PEDIATRIC ACADEMIC SOCIETIES 2024 MEETING

Retrieved on: 
Thursday, April 4, 2024

TORONTO, April 4, 2024 /PRNewswire/ -- Pediatric Academic Societies (PAS) Meeting connects thousands of leading pediatric researchers and other healthcare providers worldwide united by a common mission: Connecting the global academic pediatric community to advance scientific discovery and promote innovation in child and adolescent health.

Key Points: 
  • TORONTO, April 4, 2024 /PRNewswire/ -- Pediatric Academic Societies (PAS) Meeting connects thousands of leading pediatric researchers and other healthcare providers worldwide united by a common mission: Connecting the global academic pediatric community to advance scientific discovery and promote innovation in child and adolescent health.
  • Research on Neonatology, artificial intelligence, adolescent obesity, mental health, infectious diseases, and other health issues will be featured at the Pediatric Academic Societies (PAS) 2024 Meeting
    This unique meeting represents over 70 pediatric specialties and includes more than 350+ sessions, 687 oral abstracts, and 3,300+ posters on general and specialty pediatric health topics, as well as nine Friday pre-conference programs featuring topics on pediatric bioethics, perinatal stroke, kidney health, and more.
  • Attendees can access sessions, posters, and more through the online program guide and the PAS Meeting mobile app.
  • "This is the premier forum for pediatric researchers and providers to share the latest research on global and public health issues," Judith Shaw, PAS program chair.

Global Clinical Trials Connect Conference 2024: London, United Kingdom - May 28-29, 2024 - Registration Now Open

Retrieved on: 
Tuesday, March 26, 2024

DUBLIN, March 26, 2024 /PRNewswire/ -- The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 26, 2024 /PRNewswire/ -- The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.
  • The Global Clinical Trials Connect 2024 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research.
  • This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
  • It gives us a great pleasure in welcoming you to the Global Clinical Trials Connect 2024.

Susan G. Komen® Strengthens Leadership with Strategic Appointments to Board of Directors

Retrieved on: 
Wednesday, March 20, 2024

DALLAS, March 20, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, today announced four new global leaders to serve on its Board of Directors. These appointments mark a significant milestone in the organization's continued commitment to advancing breast cancer research, awareness and support. The newly appointed board members bring a wealth of experience and expertise to the organization, further fortifying Komen's mission to end breast cancer forever.

Key Points: 
  • These appointments mark a significant milestone in the organization's continued commitment to advancing breast cancer research, awareness and support.
  • "Komen's new board members join a legacy of passionate individuals who have dedicated themselves to making a difference," said Paula Schneider, president & CEO, Susan G. Komen.
  • Kathy Sutherland, Partner & Chief Executive Officer at GoldenTree Asset Management, brings a wealth of financial acumen and strategic leadership to the board.
  • Additional information on the Board of Directors and individual Board members can be found here: https://www.komen.org/about-komen/our-people/ .